MIFH
TEVA icon

Migdal Insurance & Financial Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.32B Buy
38,922,212
+1,020,000
+3% +$34M 8.44% 1
2026
Q1 		$1.14B Buy
37,902,212
+500,000
+1% +$16.1M 9.9% 1
2025
Q4 		$1.17B Buy
37,402,212
+4,820,000
+15% +$119M 10.04% 1
2025
Q3 		$658M Buy
32,582,212
+3,896,790
+14% +$68.4M 7.09% 1
2025
Q2 		$481M Buy
28,685,422
+2,350,000
+9% +$37.9M 5.71% 3
2025
Q1 		$405M Buy
26,335,422
+300,000
+1% +$5.36M 5.68% 1
2024
Q4 		$574M Buy
26,035,422
+569,412
+2% +$10.4M 8.23% 1
2024
Q3 		$459M Sell
25,466,010
-3,652,200
-13% -$63.9M 7.42% 1
2024
Q2 		$473M Sell
29,118,210
-739,590
-2% -$11.4M 7.9% 1
2024
Q1 		$421M Buy
29,857,800
+938,260
+3% +$11.8M 6.74% 2
2023
Q4 		$302M Buy
28,919,540
+1,860,000
+7% +$17.4M 6.08% 2
2023
Q3 		$276M Buy
27,059,540
+3,413,100
+14% +$31.8M 5.9% 3
2023
Q2 		$178M Buy
23,646,440
+299,880
+1% +$2.43M 4.12% 6
2023
Q1 		$207M Buy
23,346,560
+1,750,000
+8% +$17.3M 4.57% 6
2022
Q4 		$197M Buy
21,596,560
+216,360
+1% +$1.89M 4.38% 6
2022
Q3 		$173M Buy
21,380,200
+1,847,280
+9% +$16.3M 3.89% 6
2022
Q2 		$147M Sell
19,532,920
-1,333,640
-6% -$11.6M 3.27% 8
2022
Q1 		$196M Buy
20,866,560
+1,660
+0% +$13.9K 3.42% 2
2021
Q4 		$167M Sell
20,864,900
-419,655
-2% -$3.79M 1.61% 13
2021
Q3 		$207M Buy
21,284,555
+1,494,519
+8% +$14M 2.18% 9
2021
Q2 		$196M Buy
19,790,036
+90
+0% +$953 2.06% 10
2021
Q1 		$229M Sell
19,789,946
-5,849
-0% -$67.1K 2.3% 8
2020
Q4 		$191M Buy
19,795,795
+2,309,305
+13% +$22.1M 2.26% 9
2020
Q3 		$158M Sell
17,486,490
-4,386,500
-20% -$46.4M 2.19% 9
2020
Q2 		$270M Sell
21,872,990
-97,964
-0.4% -$1.11M 4.38% 3
2020
Q1 		$197M Buy
21,970,954
+9,249,740
+73% +$94.8M 4.58% 3
2019
Q4 		$125M Buy
12,721,214
+8,250,000
+185% +$73.7M 2.4% 11
2019
Q3 		$30.8M Buy
4,471,214
+993,219
+29% +$7.61M 0.64% 37
2019
Q2 		$32.1M Buy
3,477,995
+50,000
+1% +$603K 0.82% 30
2019
Q1 		$53.7M Buy
3,427,995
+410,260
+14% +$7.23M 1.29% 20
2018
Q4 		$46.5M Buy
3,017,735
+996,310
+49% +$20.4M 1.05% 22
2018
Q3 		$43.5M Sell
2,021,425
-204,632
-9% -$4.75M 0.9% 23
2018
Q2 		$54.1M Sell
2,226,057
-605,088
-21% -$12.3M 1.29% 17
2018
Q1 		$48.4M Sell
2,831,145
-54,000
-2% -$1.05M 1.14% 23
2017
Q4 		$54.7M Sell
2,885,145
-3,150,499
-52% -$47.4M 1.36% 20
2017
Q3 		$106M Buy
6,035,644
+259,891
+4% +$5.85M 2.52% 10
2017
Q2 		$192M Buy
5,775,753
+2,221,695
+63% +$68.8M 4.36% 4
2017
Q1 		$114M Sell
3,554,058
-1,010,502
-22% -$34.5M 2.73% 6
2016
Q4 		$165M Buy
4,564,560
+801,106
+21% +$32M 4.2% 3
2016
Q3 		$173M Sell
3,763,454
-3,703,454
-50% -$193M 4.96% 5
2016
Q2 		$375M Buy
7,466,908
+3,594,209
+93% +$191M 10.36% 2
2016
Q1 		$207M Sell
3,872,699
-210,000
-5% -$12.3M 6.35% 3
2015
Q4 		$268M Buy
+4,082,699
New +$252M 7.64% 2

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Migdal Insurance & Financial Holdings's TEVA Position: Q2 2026 in Review

Migdal Insurance & Financial Holdings increased its Teva Pharmaceuticals (TEVA) stake by 2.7% in Q2 2026, buying an estimated $34M and bringing the position to 38,922,212 shares worth $1.32B. The position accounts for 8.44% of the portfolio, ranked #1.

Migdal Insurance & Financial Holdings first reported a position in TEVA in Q4 2015 and has held it in 43 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Migdal Insurance & Financial Holdings held 38,922,212 shares of Teva Pharmaceuticals worth $1.32B as of Q2 2026.
  • Migdal Insurance & Financial Holdings bought 1,020,000 Teva Pharmaceuticals shares in Q2 2026, an estimated $34M.
  • Teva Pharmaceuticals made up 8.44% of Migdal Insurance & Financial Holdings's portfolio in Q2 2026, its #1 holding.
  • Migdal Insurance & Financial Holdings first reported a position in Teva Pharmaceuticals in Q4 2015 and has held it in 43 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2026, filed 10 Aug 2026.